Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLACONCANALDE: Cannabidiol for Alcohol Dependence
2023-504439-42-03Phase 2Authorised
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Efficacy of cannabidiol on alcohol dependence, Psychological symptoms involved in alcohol consumption and 2 more. Planned start Jun 2026; status: authorised.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2023-504439-42-03.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504439-42-03.